(2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid
C23H17FN2O4 — CID 156880489
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid
(2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid (PubChem CID 156880489) has the molecular formula C23H17FN2O4 and a molecular weight of 404.40 g/mol. Its IUPAC name is (2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid.
Molecular Properties
| Compound Name | (2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid |
|---|---|
| PubChem CID | 156880489 |
| Molecular Formula | C23H17FN2O4 |
| Molecular Weight | 404.40 g/mol |
| Exact Mass | 404.12 |
| IUPAC Name | (2R)-2-amino-2-[4-(4-fluorophenyl)-7-hydroxy-3-phenylisoquinolin-1-yl]oxyacetic acid |
| SMILES | N[C@H](Oc1nc(-c2ccccc2)c(-c2ccc(F)cc2)c2ccc(O)cc12)C(=O)O |
| InChI | InChI=1S/C23H17FN2O4/c24-15-8-6-13(7-9-15)19-17-11-10-16(27)12-18(17)22(30-21(25)23(28)29)26-20(19)14-4-2-1-3-5-14/h1-12,21,27H,25H2,(H,28,29)/t21-/m1/s1 |
| InChIKey | ABGMAMCLJMTXAW-OAQYLSRUSA-N |
| XLogP | 4.16 |
| TPSA | 105.67 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.40 |
| LogP ≤ 5 | 4.16 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156880489 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.